Harbour Investments, Inc. Protagonist Therapeutics, Inc Transaction History

Harbour Investments, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 16, 2022	SELL	$17.63 - $37.1 $2,221 - $4,674	-126 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$12.95 - $49.69 $660 - $2,534	51 Added 68.0%	126 $2,000
Q2 2021 Aug 16, 2021	BUY	$25.57 - $44.88 $51 - $89	2 Added 2.74%	75 $3,000
Q1 2021 Aug 17, 2021	BUY	$19.02 - $31.15 $1,388 - $2,273	73 New	73 $2,000

212

59.1M

19K

107K

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $2.25B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbour Investments, Inc. with notifications on news.